0001209191-19-004242.txt : 20190117
0001209191-19-004242.hdr.sgml : 20190117
20190117164918
ACCESSION NUMBER: 0001209191-19-004242
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190115
FILED AS OF DATE: 20190117
DATE AS OF CHANGE: 20190117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mohideen Pharis
CENTRAL INDEX KEY: 0001760395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 19531390
MAIL ADDRESS:
STREET 1: C/O OVASCIENCE, INC.
STREET 2: 9 FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-15
0
0001544227
Millendo Therapeutics, Inc.
MLND
0001760395
Mohideen Pharis
C/O MILLENDO THERAPEUTICS, INC.
301 N. MAIN ST., SUITE 100
ANN ARBOR
MI
48104
0
1
0
0
Chief Medical Officer
Employee Stock Option (right to buy)
8.80
2019-01-15
4
A
0
64000
0.00
A
2029-01-14
Common Stock
64000
64000
D
Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jeffery M. Brinza, Attorney-in-Fact
2019-01-17